The gene knockout technology has revolutionized the fertility/infertility field. It has revealed several essential previously undiscovered molecules, new insights and novel mechanisms involved in steps of the fertility cascade in females. Using database and literature search, knockouts of at least 83 genes were discovered that demonstrated an effect on fertility of female mice. These effects ranged from abnormality in reproductive structure, ovarian function, oocyte, fertilization, embryonic and fetal development, implantation and pregnancy to delivery. However, only a few of these knockout of genes such as encoding oocyte glycoprotein coat comprised of zona pellucida (ZP) 1, ZP2 and ZP3 and oocute plasma membrane specific proteins showed a specific and exclusive target infertility effect without concomitant effects on the non-reproductive organ system. These molecules will provide novel targets of contraception including contraceptive vaccine development.
INTRODUCTION
Infertility is failure to conceive after one year of unprotected intercourse.
Female infertility can be attributed to defect in ovarian development, proliferation and maturation of oocytes, differentiation of granulosa and theca cells, ovulation, tubal transport of oocyte, timed coital delivery of sperm, cervical mucus receptivity, fertilization and/or the implantation of embryo into the uterine endometrium. These defects can result from deficiency or abnormality of several intragonadal and extragonadal factors (1) . These factors are involved in initiation of follicular growth and development of the oocyte, granulosa cells and theca cells both in early and late stages of folliculogenesis, and in regulating the physiology of various reproductive organs (2) . Among the female factors responsible for infertility, the ovulatory problems constitute the majority (40%), which could in turn result from lack of required number of follicles within the ovary and/or to irregular hormonal concentration. Over 30% of infertile females have disorders in the tubal transport and another 3% have infertility associated with endometriosis. Coital/cervical problems constitute ~13% of female infertility and 10% are attributed to unexplained causes (http://medstat.med.utah.edu /kw/human_reprod).
Physiological, biological and molecular studies have helped us to understand the process of gonadogenesis, folliculogenesis and other aspects of infertility. The advent of gene knockout technology has provided a great impetus to study the role of various genes and proteins in fertility and infertility (3) (4) (5) (6) . This technology provides a phenotype to examine resulting from the functional deletion of a gene. In addition to the "classic gene-knockouts", the lox/cre system has now been used to get conditional gene-knockouts that prevent formation of lethal phenotypes which might be produced by the classical method due to inactivity of key biologically essential enzymes (7) . The aim of this review is to identify the gene knockout mice that have been shown to have an effect on female fertility. Using search in the database (http://www.humgen.nl/orgspecdatabases.html#Mouse) and studies on reported gene knockouts in the literature (http://www.ncbi.nlm.nih.gov/entrez), a total of 83 genes were identified as of January 14, 2005 whose knock out (KO) caused female infertility in mice (table 1). The knockout can be broadly divided into five broad categories depending upon which parameter(s) of female fertility is affected by a particular gene deletion. These categories are described below.
DISCUSSION

Gene knockouts affecting gonadogenesis and ovarian function
A total of seven genes were found in this category (table 1). The development of the ovary occurs during the early fetal life from an extraembryonic mass of cells that migrate to gonadal ridges of developing embryo. The germ cells form important association with somatic cells of the gonad for the duration of germ cell development and female reproductive life span. The ovarian development is controlled by several transcriptional factors, nuclear multi-protein core complex and hormonal receptor mediated factors. The knockout of Zfx gene, encoding for an X-chromosome located zinc-finger transcription factor, demonstrates a role of this protein in sex differentiation and in premature ovarian failure (8) . The knockout of WT-1 gene, another transcription factor gene, affects the urogenital development during sex determination resulting in ovarian agenesis (9) . Sox 3 is an X-chromosome coded transcription factor gene of high mobility group (HMG) family expressed in brain during early development and gonads. The mutants of this gene develop follicle atresia and defective oocyte formation and are infertile (10) . Cytokine-activated signaling molecule, Stat 3 , is expressed in brain during development and growth, and affect transcription by direct binding to DNA of target genes (11) .
Its non-expression leads to hypogonadotrophic hypogonadism and several reproductive organ disorders due to gonadotrophic abnormalities. Gonadal agenesis has been reported in gene knockouts of nuclear receptor superfamily steroidogenic factor coding gene, Ftz-F1 (12) .
Another gene responsible for hypogonadism is the nuclear multi-protein core complex protein Fanconi anemia complementation group, Fanc (13) (14) (15) . Since these genes have varied roles in development of other tissues, their deletion leads to a variety of organ defects.
Gene knockouts affecting folliculogenesis and germ cell development
A total of 33 genes were found in this category (table 1 ). An ovarian follicle consists of an oocyte surrounded by granulosa and theca cells.
The folliculogenesis involves co-coordinated steps of initiation of oocyte growth from primordial follicles, granulosa and theca cell differentiation and proliferation, and finally development of the antral follicle. These well-knit patterns of events result in a continuous recruitment of preovulatory follicles during each ovarian cycle. The development of a viable and fully functional oocyte is one of the crucial events in reproduction.
Three coat proteins of the oocyte, the zona pellucida (ZP) proteins, ZP1, Zp2 and Zp3 (coded by Zp1, Zp2 and Zp3, respectively) are very important for the structural integrity of the zona pellucida and thereby for the functional viability of oocyte. The knockouts of these three genes have been shown to have a drastic effect on fertility (16) (17) (18) (19) . The proliferation of germ cells and their migration to the genital ridges are controlled by a protein called the proliferation of germ cells (Pog) encoded by Pog, the deletion of which results in the depletion of follicles in the developing ridges (20) . This protein is expressed widely in the embryo and its deletion causes germ cell deficient phenotype. Dazla protein is a cytoplasmic protein that controls the translation in maturing oocyte by localization or packaging of mRNA (21) . Deletion of the Dazla gene, leads to lack of germ cells due to a prenatal degeneration. This protein is shown to have an effect on both male and female gonads. An oocyte-derived growth factor, GDF-9, is transcribed only in the oocyte. The Gdf-9 KO mice show a block in the follicular development at the one-layer stage leading to complete infertility (22) . A similar protein GDF9b (Bone morphogenetic protein 15) encoded by Bmp 15 gene, is also secreted by the oocytes and its deletion affects ovarian folliculogenesis, cumulus physiology and ovulation (23) . Gja 4 encodes for an intracellular signaling protein Connexin 37 , that is present in the gap junctions between oocyte and granulosa cells. The Gja 4 KO mice result in a block in maturation of Graffian follicles beyond meiotic competence and hence there is no ovulation (24) . Similar arrest of the oocytes at the pachytene stage is seen in KO mice deleted off Cpeb gene, a cytoplasmic polyadenylation element binding protein that regulates translation during the oocyte maturation (25) . Factor in the germline α (Figla), is a germ-cell specific factor that coordinates expression of the zona proteins. A KO of this gene results in sterility (26) .
Besides these, there are several other gene knockout of female mice that have a reduced fertility as shown in table 1. Majority of these knockouts not only have an effect on fertility but also affect growth and development of somatic cell function in a variety of organs.
Gene knockouts affecting ovulation, fertilization and post-fertilization embryonic development
A total of 24 genes were found in this category (table 1) . The normal endpoint of a developing oocyte is either the apoptotic demise or ovulation resulting from the LH surge. This process is followed by morphological and physiological changes in the ovary called luteinization. The oocyte release and formation of the corpus luteum are important events in the process of conception and maintenance of pregnancy. The released oocyte is arrested at metaphase II. After ejaculation, the spermatozoa undergo capacitation in the female genital tract and then acrosome react to release proteolytic enzymes required to assist zona penetration and fusion of sperm membrane with oocyte membrane. The sperm cell entry induces a release of second polar body from oocyte nucleus to make it haploid. This is followed by fusion of two pronuclei to form a zygote that undergoes cleavage resulting in an embryo. The timed hormonal signals prepare the endometrium for receiving the embryo. The decidualization of the uterus is induced by signals from the blastocyst and several factors determine implantation and further growth of the embryo. Several genes are involved in these processes, some of these are discussed below.
Gene knockouts of prolactin receptors (PRLR) affect function of prolactin, resulting in multiple reproductive abnormalities including irregular menstrual cycles and failure of implantation, thus causing reduced fertility (53, 54) . The embryo development is affected by deletion of genes such as mater (55) and Dnmt 1o (56) , encoding for proteins that are important for the growth and differentiation of the embryo. The mater encodes for maternal antigen mRNA or proteins that accumulate in the egg during oogenesis. The absence of these proteins in gene knockout mice results in failure of the embryo to develop beyond the two-cell stage. Dnmt 1o, encodes a variant of DNA methyltransferase that is expressed specifically in the oocyte and pre-implantation embryo. It affects the genomic methylation pattern. The failure of maintenance of the methylation patterns lead to embryo death. One of the surface proteins of the sperm is a sperm adhesion molecule, PH 20 (Spam 1), a hyaluronidase bound to the inner acrosomal membrane, which helps sperm in penetration into oocyte. The knockout of Spam 1 leads to decreased fertility (57) . A similar GPI-anchored protein on the egg surface, Nacetyl glucosaminyl transferase, encoded by Ptga gene, is involved in the sperm-oocyte membrane interaction (58) . Conditional mutants without the gene expression show no fertility due to lack of this protein on the surface of the oocyte.
There are several additional genes that affect ovulation, fertilization, and post-fertilization embryonic development (59) (60) (61) (62) (63) (64) (65) (66) (67) (68) (69) (70) (71) (72) (73) (74) (75) (76) (77) (78) . The effects of their knockout have been described in table 1.
Gene knockouts affecting female reproductive structures
A total of six genes were found in this category (table 1) .
Several genes that are involved in the development of non-reproductive organs are also involved in development of reproductive system. A family of signaling molecules, Wnt proteins, encoded by Wnt genes, has been shown to affect morphogenesis of embryonic layers. Wnt 7a KO causes Mullerian duct-associated sterility due to abnormal oviduct and uterus development (79) . Wnt 7b KO causes embryonic death at mid-gestational stage (80) . Hoxa 11 are homeobox genes that specify regional specification during development (81) . Their knockouts show defective uterine development that cannot support embryo growth.
Also, in this group are cytochrome P450 ( Cyp 40) (82), centromere protein B (Cenpb) (83) and transmembrane ATP-binding cassette transporter protein (Abca 1) (84) . Their gene knockouts result in formation of malformed placenta, severe disruption of uterine epithelium and uterus hypoplasia, respectively. Their KOs have severe effects on embryonic development. They are either lethal or have severe structural deformities.
Gene knockouts affecting endocrine milieu
A total of 13 genes were found in this category (table 1) . Hormones regulate every stage of reproductive growth and differentiation from gonadogenesis, folliculogenesis, ovulation, fertilization, embryo and fetal development, implantation, pregnancy and delivery. The gene KO of a hormone or its effector could have an effect on a specific fertility target. An interesting example among them is the knock out of gonadotrophin FSH β subunit (FSH). The infertility in this KO is due to block in folliculogenesis before the antral follicle formation with a uterine and ovarian hypertrophy. This gene also affects spermatogenesis and Sertoli cell function in males (43, 85) . Prolactin (PRL) is responsible for several post-pubertal changes. Besides, the lack of PRL also leads to abnormalities in menstrual cyclicity. Defects are also seen in several other reproductive tissues involved in healthy fetal growth (86) . Insulin-like growth factor ( IGF-1) is required for granulosa cell proliferation by FSH. The IGF-1 KO mice show no responsiveness to FSH that is required for growth of follicles (87) . Anti-Mullerian hormone (Amhr 2 ), a growth and differentiation factor of TGF superfamily, is required for growth and differentiation of Mullerian ducts.
The hormone is also synthesized, postnataly, by ovary and Sertoli cells. Lack of this hormone results in an early depletion of primary follicles (88) . Insulin-like hormone, (encoded by gene Insl 3) is expressed both in ovary and testis. Its depletion results in irregular cyclicity thereby leading to severe lowering of the litter size (89) in females. The hormone also mediates the testicular descent in males. Another regulatory protein that modulates progesterone-mediated reproductive behavior is protein phosphatase 1 subunit 1B, a dopamine-and adenosine 3', 5'-monophosphate (cAMP)-regulated phosphoprotein (DARPP-32) (90) . The Ppp1r1b gene that encodes DARPP-32 constitutes an intermediate in the progesterone-mediated sexual receptivity in female rats and mice. The gene KO showed abnormal reproductive behavior. Other similar genes are described in table 1 (91-98).
CONCLUSION
The gene knockout studies have revealed several essential molecules, new insights and novel mechanisms involved in various steps of the fertility cascade in females. At the present time 83 gene knockouts were found in the database and literature that show an effect on female fertility. The fertility field has exploded with the advent of gene knockout technology. Almost every month there is a report on a new gene knockout with some effect on fertility. However, there are only a few genes whose knockouts have shown a specific effect on female fertility without a concomitant effect on non-reproductive systems. Among these specific molecules are, the oocyte coating zona pellucida proteins (ZP1, ZP2 and ZP3) involved in sperm recognition and binding and oocyte membrane proteins that are involved in fusion with sperm membrane. These proteins may provide novel targets for contraception and/or for contraceptive vaccine development. The utility of a protein in contraception is contingent upon its 1) oocyte specificity, 2) essential role in gamete/ovarian function and 3) accessibility and amenability of inactivation by inhibitors, antagonists or antibodies. These inhibitors/antagonists/antibodies should not affect follicullogenesis/endocrine milieu and should have a reversible effect on fertility without causing premature ovarian failure (POF) or menopause. The gene knockout technology is helping us to better understand female infertility and is opening up potential novel targets for contraceptive development.
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